Get startedLog in
    Picture of Xeris Biopharma Holdings logo

    XERS — Xeris Biopharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Xeris Biopharma Holdings Reaffirms 2025 Revenue Guidance Of $260-$275 Million

    Picture of Xeris Biopharma Holdings logoXeris Biopharma Holdings
    03/06/2025 12:34
    June 3 (Reuters) - Xeris Biopharma Holdings Inc XERS.O:

XERIS BIOPHARMA HOLDINGS INC - REAFFIRMS 2025 REVENUE GUIDANCE OF $260-$275 MILLION

XERIS BIOPHARMA HOLDINGS INC - EXPECTS 2030 REVENUE OF ABOUT $750 MILLION

Source text: ID:nBw8dWCbXa

Further company coverage: XERS.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Xeris Biopharma Holdings

    See all news